JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JAMA Dermatology. Home New Online Current Issue For Authors. Podcast. Journals JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA …JAMA Dermatology. Key Points. Question What are the safety, efficacy, and biomarker responses of dupilumab treatment in patients with erythrodermic atopic dermatitis (AD)? Findings In this post hoc analysis of 209 patients with erythrodermic AD in 6 randomized, placebo-controlled clinical trials, dupilumab treatment (either as …21 Apr 2021 ... Findings In this cross-sectional time-series study of 8049 dermatology clinic visits by 4147 patients, short-term wildfire-associated air ...JAMA Dermatology. Home New Online Current Issue For Authors. Podcast. Journals JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA …Explore health information written for patients from JAMA Dermatology’s editors, including easy-to-understand explanations of atopic dermatitis, psoriasis, and more. Add to My …[email protected] Hours: 8:30 AM to 4:45 PM CT Monday through Friday USA & Canada: +1 800.262.2350 Rest of World: +1 312.670.7827. Phone: 1-312-464-4444 Hours: 7:00 AM to 5:00 PM CT Monday through Friday. Instructions for Authors and Information on Submitting Manuscripts. [email protected] JAMA Network Open …The VU Journal Publishing Guide shows you the most important scientific journals in your field, with their impact metrics, Open Access possibilities and APC ...18 Apr 2018 ... Based on these findings, the study suggests that the “diagnostic accuracy of PAs may be lower than that of dermatologists.” However, the study ...Eleven women presented with chronic severe pain and/or pruritus of the scalp only without objective physical findings, a condition we term "scalp dysesthesia." Five women described pain, stinging, or burning only; 4 women complained of pain and pruritus; and 2 women reported pruritus only. The patients ranged in age from 36 to 70 years.This association was stronger among those studies conducted for dermatologic indications as well as among JAK1-specific, combined JAK1 and JAK2, and tyrosine kinase 2–specific inhibitor treatments. Meaning These findings suggest that patients should be properly counseled on the potential adverse effect of acne before beginning treatment with ... Medicine Matters Sharing successes, challenges and daily happenings in the Department of Medicine ARTICLE: Factors Associated With Overuse of Health Care Within US Health System AU...JAMA Dermatology. Abstract Importance Oral isotretinoin has been associated with several adverse effects, but evidence-based estimates of laboratory changes during isotretinoin therapy in large patient samples are limited. Objective To develop estimates of the laboratory changes that occur during isotretinoin therapy for acne using extant data …JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JAMA Dermatology. Home New Online Current Issue For Authors. Podcast. Journals JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA …Disclaimer: Dr Barbieri is the CME/Clinical Review and Education Editor of JAMA Dermatology but was not involved in any of the decisions regarding review of the manuscript or its acceptance. References 1. Lainscak M , Pelliccia F , Rosano G , et al. Safety profile of mineralocorticoid receptor antagonists: spironolactone and eplerenone. …JAMA Dermatology. Key Points. Question Does the 9-valent human papillomavirus vaccine have therapeutic utility for cutaneous squamous cell carcinoma? Findings A woman in her 90s with multiple cutaneous squamous cell carcinomas was treated with the 9-valent human papillomavirus vaccine systemically and intratumorally. This approach led to regression …Bickers DR , Lim HW , Margolis D , et al; American Academy of Dermatology Association; Society for Investigative Dermatology. The burden of skin diseases: 2004 a joint project of the American Academy of Dermatology Association and the Society for Investigative Dermatology. Dermatology Times - Spironolactone shows promise for hormonal acne. Dermatology Times Spironolactone shows promise for hormonal acne. JAMAJAMA Dermatology. JDD ...6 days ago · Hamilton Centre's independent member of provincial parliament Sarah Jama says she will table motions next week at Queen's Park that would boost Ontario Works, …Explore the latest in dermatology, including diagnosis and management of allergic, inflammatory, autoimmune and genetic diseases of the skin. Publication. All Publications.The JAMA Dermatology Patient Page is a public service of JAMA Dermatology. The information and recommendations appearing on this page are appropriate in most instances, but they are not a substitute for medical diagnosis. For specific information concerning your personal medical condition, JAMA Dermatology suggests that you consult your …JAMA Dermatology. Key Points. Question Are melanomas diagnosed through routine skin checks (a proxy for skin cancer screening) associated with reduced melanoma-specific and all-cause mortality? Findings This population-based cohort study included 2452 patients, each with 1 diagnosed melanoma, 35% of which were detected during a routine skin …JAMA Dermatology. Full Text. Atopic dermatitis (AD) is a pruritic, chronic inflammatory skin disease characterized by recurrent flares and a family history of atopy. A hallmark feature of AD is epidermal barrier dysfunction that activates type 2 immune cells, which release Th2 cytokines (IL-4, IL-13, IL-31, and IL-22) that promote inflammation, B-cell IgE class …In dermatology practice, patients frequently present with a recalcitrant eruption distinguished by the presence of edematous, urticarial, intensely pruritic papules. After analysis of patient biopsy specimens, the dermatopathologist will often report a “dermal hypersensitivity reaction” (DHR) characterized by an eosinophil-rich infiltrate.JAMA Dermatology. Home New Online Current Issue For Authors. Podcast. Journals JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA …This phase 2b, placebo-controlled, randomized clinical trial evaluates the efficacy and safety of lebrikizumab, a novel, high-affinity, monoclonal antibody targeting interleukin (IL)–13 that selectively prevents formation of the IL-13Rα1/IL-4Rα heterodimer receptor signaling complex, in adults with... JAMA Dermatology. Home New Online Current Issue For Authors. Podcast. Journals JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA …30 Aug 2023 ... JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology ...Dr Micheletti is Images in Dermatology Editor for JAMA Dermatology. Dr Rosenbach is an Editorial Board member of JAMA Dermatology. Dr Shields is an Assistant Section Editor of JAMA Dermatology. Dr Shinkai is Chief Editor of JAMA Dermatology. Dr Mostaghimi is an Associate Editor of JAMA Dermatology. They were not involved in any of the decisions ... JAMA Dermatology. Home New Online Current Issue For Authors. Podcast. Journals JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA …JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JAMA Dermatology is committed to patient privacy throughout the publication process 9; if the content of a submission is identifiable in any way—even if only to the patient or their family—permission should be obtained. For more information, refer to our Instructions for Authors of Images in Dermatology. 10. Back to top. Article InformationImportance There is a paucity of evidence to guide physicians regarding prevention strategies for cutaneous squamous cell carcinoma (CSCC) in solid organ transplant recipients (SOTRs).. Objective To examine the development and results of a Delphi process initiated to identify consensus-based medical management recommendations for …Disclaimer: Dr Robinson is the editor of JAMA Dermatology but was not involved in the editorial review or the decision to accept the manuscript for publication. Additional Contributions: Steve Eilers, MD, Francisco Acosta, BA, Mark Anderson, MA, Hanz Blatt, MA, Rikki Gaber, BA, Yanina Guevara, BA, Ashley Juengling, BA, and Katie Reidy, MA, …Figures E-H are adapted from figures previously published in JAMA Dermatology. 10. Table 1. Summary of the BWH and AJCC 8 Tumor Classification Systems. View Large Download. Table 2. Evaluation of BWH and AJCC 8 Tumor Classification System Homogeneity and Monotonicity a. View Large Download. Table 3. Evaluation of BWH …The JAMA Dermatology Patient Page is a public service of JAMA Dermatology. The information and recommendations appearing on this page are appropriate in most instances, but they are not a substitute for medical diagnosis. For specific information concerning your personal medical condition, JAMA Dermatology suggests that you consult your …JAMA Dermatology. Hyperpigmentation is a common cutaneous concern in individuals with skin of color, 1 often leading to psychosocial distress. 2 Given the lack of rigorous clinical studies, expert opinion guides accepted treatment algorithms. Acquired facial hyperpigmentation commonly presents as melasma or postinflammatory …JAMA Dermatology. Key Points. Question Can tape strips serve as a minimally invasive approach to assess biomarkers for early-onset pediatric atopic dermatitis? Findings In this cross-sectional study of 51 children younger than 5 years with and without atopic dermatitis, the use of tape strips, a minimally invasive approach for …Also known as pernio-likepseudo-chilblain, acute acro-ischemia, and “COVID toes,” the pattern of acral lesions is described as erythematous to purple purpuric macules, papules, and/or vesicles. Its close temporal appearance with the COVID-19 pandemic suggests that the two are associated. Galván Casas et al confirmed that 29 of 71 cases of ...Necrobiotic xanthogranuloma (NXG) is a rare systemic disease first described by Kossard and Winkelmann 1 in 1980, and about 100 cases have been reported since then. 2-5 It is clinically characterized by indurated yellowish to red-orange or brown papules or nodules that grow into larger and in some cases very extensive plaques covering the face …Importance Infantile hemangiomas involute to some extent, but they often leave sequelae that may cause disfigurement. Factors determining the risk of permanent sequelae after regression are of crucial importance in treatment decision making. Objectives To describe the sequelae left by infantile hemangiomas after natural involution and to identify clinical …Before dermatology evaluation, he was treated for presumed facial impetigo with mupirocin, 2%, ointment and condyloma with imiquimod, 5%, cream. Examination demonstrated 2 umbilicated and ulcerated, skin-colored papules on the genitals, as well as a honey-colored crusted papule on the face ( Figure ).In individual patients, the risks and benefits of WW and treatment can be weighed using this algorithm. The frequency of follow-up visits (eg, every 3-6 months) should be based on the feasibility for individual cases and can be adjusted (preferably by visiting a dermatology outpatient clinic when feasible; if not possible, eg, follow-up through teledermatology or general practitioner) when ... Key Points. Question What are the recommended methods for early detection and prognostic assessment of cutaneous melanoma?. Findings In this consensus statement, via a modified Delphi method, melanoma experts supported a risk-stratified approach to various aspects of melanoma screening as well as the use of visual and dermoscopic examination, the interpretation of reflectance confocal ... JAMA Dermatology Hyperpigmentation is a common cutaneous concern in individuals with skin of color, 1 often leading to psychosocial distress. 2 Given the lack of rigorous clinical studies, expert opinion guides accepted treatment algorithms. Hidradenitis suppurativa (HS) is relatively common, with the prevalence of 0.05% to 4.10%, yet many patients receive inadequate treatment. To review the diagnosis, epidemiology, and treatment of HS with an emphasis on advances in the last 5 years. A literature search was conducted using PubMed, MEDLINE (Medical Subject Headings …Jan 24, 2024 · The JAMA Dermatology Patient Page is a public service of JAMA Dermatology. The information and recommendations appearing on this page are appropriate in most instances, but they are not a substitute for medical diagnosis. For specific information concerning your personal medical condition, JAMA Dermatology suggests that you consult your ... Psoriasis is a chronic skin condition caused by skin cells that multiply faster than normal due to a dysregulated immune system. Plaque psoriasis is the most common type of psoriasis, representing approximately 80% to 90% of cases. Typical plaque psoriasis appears as red, raised areas of skin (plaques), often covered with a characteristic ...JAMA Dermatology. Home New Online Current Issue For Authors. Podcast. Journals JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA …17 Feb 2023 ... The goal of this fellowship is to support the development of an early-career academic dermatologist to equip them with the skills to take on ...JAMA Dermatology. Key Points. Question Can 2-photon fluorescence microscopy enable rapid point-of-care diagnosis of nonmelanoma skin cancer through real-time imaging of unprocessed fresh tissue biopsies? Findings In this pilot comparative effectiveness research study using 2-photon fluorescence microscopy on 15 biopsies of known non-melanoma …23 Mar 2022 ... JAMA Dermatology—The Year in Review, 2021 ... In the face of uncertainty and an ever-evolving global pandemic, JAMA Dermatology continued to ...The most common dermatologic treatment during a flare episode was topical corticosteroids (35% of flare episodes [178 of 513]) followed by other oral dermatologic treatments (eg, methotrexate, cyclosporine, tacrolimus; 13% [67 of 513]), and oral corticosteroids (11% [54 of 513]) . Opioids were prescribed during 21% of flare episodes (106 of 513). JAMA Dermatology’s mission is to elevate the art and science of health and diseases of skin, hair, nails, and mucous membranes, and their treatment, to enable dermatologists to deliver evidence-based, high-value medical and surgical dermatologic care. Key Points. Question What is the efficacy and safety of 4 mg and 2 mg of baricitinib in combination with background topical corticosteroid (TCS) therapy in adults with moderate to severe atopic dermatitis (AD)?. Findings In this randomized clinical trial of 329 adults with moderate to severe AD, at week 16, a validated Investigator Global Assessment for …9 Aug 2023 ... Kwatra, MD, Department of Dermatology, Johns Hopkins University School of Medicine, 1550 Orleans St, Koch CRBII, Room 206, Ste 216, Baltimore, ...Omega-3s were supposed to protect us all from heart disease and other health problems, but it’s taken some time for the evidence to catch up with the hype around these supplements....Disclaimer: Dr Adamson is an Associate Editor and Web Editor of JAMA Dermatology, but he was not involved in any of the decisions regarding review of the manuscript or its acceptance. References: 1. Chen ST , Geller AC , Tsao H . Update on the epidemiology of melanoma. Curr Dermatol Rep. 2013;2(1):24-34. doi:10.1007/s13671 ...JAMA Dermatology Clinicopathological Challenge . October 12, 2022. Numerous Angiomatous Lesions in an Infant. Catherine Reilly, BS 1; Nidhi Shah, MD 2; Kaiane Habeshian, MD 3. Author Affiliations Article Information. 1 Georgetown University School of Medicine, Washington, DC. 2 George Washington University School of Medicine and …Hidradenitis suppurativa (HS) is relatively common, with the prevalence of 0.05% to 4.10%, yet many patients receive inadequate treatment. To review the diagnosis, epidemiology, and treatment of HS with an emphasis on advances in the last 5 years. A literature search was conducted using PubMed, MEDLINE (Medical Subject Headings …JAMA Dermatology. Key Points. Question Does the 9-valent human papillomavirus vaccine have therapeutic utility for cutaneous squamous cell carcinoma? Findings A woman in her 90s with multiple cutaneous squamous cell carcinomas was treated with the 9-valent human papillomavirus vaccine systemically and intratumorally. This approach led to regression …Resident's Page · 1. Montgomery H, Winkelmann RK: Smooth-muscle tumors of the skin . · 2. Fisher WC, Helwig EB: Leiomyomas of the skin . · 3. Kloepfer HW,&...JAMA Dermatology. Abstract Importance Isotretinoin is the most effective treatment for acne. The ideal dosing regimen is unknown. Objective To determine the rates of relapse of acne vulgaris and retrial of isotretinoin after high cumulative-dose treatment and the changes to the adverse effect profile. Design, Setting, and Participants ...Feb 14, 2024 · Systemic Immunomodulatory Treatments for Atopic Dermatitis. Explore the latest treatments for vitiligo, hidradenitis suppurativa, lichen sclerosus, melanoma, cosmetic dermatology, and more. Formerly Archives of Dermatology. JAMA Dermatology. Audio Author Interview (16:22) Natural Does Not Mean Safe. 1x. 0:00 / 0:00. Subscribe to Podcast. Clean beauty, also known as natural skin care, is having a …JAMA Dermatology. Key Points. Question Can 2-photon fluorescence microscopy enable rapid point-of-care diagnosis of nonmelanoma skin cancer through real-time imaging of unprocessed fresh tissue biopsies? Findings In this pilot comparative effectiveness research study using 2-photon fluorescence microscopy on 15 biopsies of known non-melanoma …JAMA Dermatology. Key Points. Question What is the efficacy and safety of bimekizumab in individuals with moderate to severe hidradenitis suppurativa (HS)? Findings In this double-blind, placebo-controlled, phase 2 randomized clinical trial including 90 randomized patients with HS (73 completed the trial), bimekizumab demonstrated clinically …JAMA Dermatology. Key Points. Question What is the short-term and long-term comparative efficacy among biologics and oral agents for plaque psoriasis? Findings In a network meta-analysis of 60 clinical …JAMA Dermatology. Key Points. Question What is the diagnostic accuracy of clinical examination and baseline ultrasonography for the detection of regional lymph node metastasis in patients with high-risk cutaneous squamous cell carcinoma (SCC) of the head and neck, and what is the diagnostic accuracy of ultrasonography among patients with …21 Apr 2021 ... Findings In this cross-sectional time-series study of 8049 dermatology clinic visits by 4147 patients, short-term wildfire-associated air ...JAMA Dermatology. Home New Online Current Issue For Authors. Podcast. Journals JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA …Key Points. Question What were the treatment patterns for alopecia areata (AA) in adults in the US from 2015 to 2020?. Findings In this cohort study of 45 483 adults with AA, on the basis of US medical and pharmacy claims data, most common treatments for AA included intralesional, topical, intramuscular, and oral corticosteroids. JAMA Dermatology. Home New Online Current Issue For Authors. Podcast. Journals JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA …Importance: Atopic dermatitis (AD) is a chronic, recurrent, inflammatory skin disease with an unmet need for treatments that provide rapid and high levels of skin clearance and itch improvement. Objective: To assess the safety and efficacy of upadacitinib vs dupilumab in adults with moderate-to-severe AD. Design, setting, and participants: …Key Points. Question What is the association of cutaneous immune-related adverse events (cirAEs) with mortality in treatment with immune checkpoint inhibitor (ICI) therapy for patients with cancer?. Findings In this retrospective cohort study of 7008 patients with cancer who developed cirAEs after treatment with anti–programmed cell death 1 or …6 Jul 2022 ... JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA ... Acta Derm Venereol. 2020;100(19): ...Importance Toxic epidermal necrolysis (TEN) and Stevens-Johnson Syndrome (SJS) are rare, acute, life-threatening dermatologic disorders involving the skin and mucous membranes. Research into these conditions is hampered by a lack of standardization of case reporting and data collection. Objective To establish a standardized case report …JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959)JAMA Network is a consortium of peer-reviewed medical publications that includes JAMA® and the JAMA Network journals. JAMA Dermatology does not hold itself responsible for statements made by any contributor. All articles published, including opinion articles, represent the views of the authors and do not reflect the policy of the Journal, the ...
Psoriasis is a chronic skin condition caused by skin cells that multiply faster than normal due to a dysregulated immune system. Plaque psoriasis is the most common type of psoriasis, representing approximately 80% to 90% of cases. Typical plaque psoriasis appears as red, raised areas of skin (plaques), often covered with a characteristic .... Ketv news omaha
This phase 2b, placebo-controlled, randomized clinical trial evaluates the efficacy and safety of lebrikizumab, a novel, high-affinity, monoclonal antibody targeting interleukin (IL)–13 that selectively prevents formation of the IL-13Rα1/IL-4Rα heterodimer receptor signaling complex, in adults with... JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JAMA Dermatology. Home New Online Current Issue For Authors. Podcast. Journals JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA …This treatment could potentially offset the increased risk of developing nonmelanoma skin cancer; 50.0% of the participants in our study reported a history of skin cancer compared with the national average of 20.0%. 17 Of note, 8 participants had hyperlipidemia, 3 of whom were receiving oral statin therapy.Importance Poor therapeutic results have been reported in patients with alopecia areata totalis (AT) or universalis (AU), the most severe and disabling types of alopecia areata (AA). Methotrexate, an inexpensive treatment, might be effective in AU and AT. Objective To evaluate the efficacy and tolerance of methotrexate alone or combined with low-dose …Corresponding Author: Ruth Ann Vleugels, MD, Department of Dermatology, Brigham and Women’s Hospital, Harvard Medical School, 75 Francis St, Boston, MA 02115 ([email protected]). Author Contributions: Dr Vleugels had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of …Spironolactone is an androgen receptor antagonist that is an effective treatment for hormonally mediated acne. 1-4 Although generally well tolerated, spironolactone use is associated with hyperkalemia among patients with heart failure taking additional drugs that interfere with potassium excretion. 5 However, the prevalence of spironolactone-induced …Interviews with authors of articles from JAMA Dermatology. JAMA Dermatology covers research on the skin, its diseases, and their treatment.JAMA Network is a consortium of peer-reviewed medical publications that includes JAMA® and the JAMA Network journals. JAMA Dermatology does not hold itself responsible for statements made by any contributor. All articles published, including opinion articles, represent the views of the authors and do not reflect the policy of the Journal, the …Dermatology Times - Spironolactone shows promise for hormonal acne. Dermatology Times Spironolactone shows promise for hormonal acne. JAMAJAMA Dermatology. JDD ...Disclaimer: Dr Micheletti is an Images in Dermatology Editor and Dr Shinkai is Editor of JAMA Dermatology, but they were not involved in any of the decisions regarding review of the manuscript or its acceptance. Data Sharing Statement: See Supplement 2. JAMA Dermatology welcomed Mya Roberson, MSPH, PhD, Vanderbilt University, as the inaugural Associate Editor of Diversity, Inclusion, and Equity to lead further development of journal initiatives in partnership with this network team. 15 The journal’s Editorial Fellowship pilot program 16 will launch in the summer of 2023, with a call for applications in the late …Bickers DR , Lim HW , Margolis D , et al; American Academy of Dermatology Association; Society for Investigative Dermatology. The burden of skin diseases: 2004 a joint project of the American Academy of Dermatology Association and the Society for Investigative Dermatology. .